1 not yet recruiting, 1 recruiting, 1 unknown. .
Follow gender-affirming hormone therapy: new trials by email Literature Review of gender-affirming hormone therapy trials Research Report on gender-affirming hormone therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study gender-affirming hormone therapy, Gender-Affirming Surgery, HIV Pre-Exposure Prophylaxis - Headache, Migraine | Not yet recruiting | Chulalongkorn University | 500 | 2026-11-01 | 2026-09-14 | |
| Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content gender-affirming hormone therapy - Gender Dysphoria, Hormone Therapy Induced Morphologic Change | Recruiting | Medical University of Vienna | 50 | 2023-03-03 | 2025-09-26 | |
| Metabolic Consequences of Cross-sex Hormonal Treatment Gender-affirming hormone therapy - Gender Dysphoria | Unknown | Central Hospital, Nancy, France | 98 | 2020-07-24 | 2020-08-11 |
Gender Dysphoria (2) · Headache (1) · Migraine Disorders (1)
Central Hospital, Nancy, France (1) · Chulalongkorn University (1) · Medical University of Vienna (1)
Austria (1) · France (1) · Thailand (1)
Akarin Hiransuthikul, M.D., M.Sc. (1) · Alexandra Kautzky-Willer, Prof, MD (1) · Jakkrapatara Boonruang, M.D. (1) · Prakit Anukoolwittaya, M.D. (1) · Sekh Thanprasertsuk, M.D. (1) · Sirawit Roongrojwittayakul, M.D. (1)
PMID 34363408, PMID 34463974, PMID 40251852, PMID 40495044, PMID 41103036